118 related articles for article (PubMed ID: 38073300)
21. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
22. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
Yan P; Cheng M; Wang L; Zhao W
Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
[TBL] [Abstract][Full Text] [Related]
23. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
25. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
Deng Z; Feng Q; Zhao D; Huang Z
Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
[TBL] [Abstract][Full Text] [Related]
26. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
27. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
[TBL] [Abstract][Full Text] [Related]
28. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
[TBL] [Abstract][Full Text] [Related]
29. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
[TBL] [Abstract][Full Text] [Related]
30. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
Chen Z; Cheng G
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37691229
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
32. ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer.
Gu W; Sun H; Zhang M; Mo S; Tan C; Ni S; Yang Z; Wang Y; Sheng W; Wang L
Cancer Med; 2023 Jan; 12(2):1520-1531. PubMed ID: 35864742
[TBL] [Abstract][Full Text] [Related]
33. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
34. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy.
Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y
Front Genet; 2022; 13():975404. PubMed ID: 36699444
[No Abstract] [Full Text] [Related]
35. Construction and validation of a novel senescence-related risk score can help predict the prognosis and tumor microenvironment of gastric cancer patients and determine that STK40 can affect the ROS accumulation and proliferation ability of gastric cancer cells.
Sun W; Yuan Y; Chen J; Bao Q; Shang M; Sun P; Peng H
Front Immunol; 2023; 14():1259231. PubMed ID: 37915566
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma.
Pan D; Chen H; Xu J; Lin X; Li L
BMC Gastroenterol; 2023 Nov; 23(1):399. PubMed ID: 37978443
[TBL] [Abstract][Full Text] [Related]
38. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K
J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
40. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
